Abstract: The invention provides heparanase inhibitors suitable for treatment of diseases and disorders caused by or associated with heparanase catalytic activity such as cancer, inflammatory disorders and autoimmune diseases.
Type:
Application
Filed:
February 6, 2005
Publication date:
August 9, 2007
Applicant:
Insight Bioharmaceuticals Ltd.
Inventors:
Joel Van Gelder, Yochai Basel, Boris Kraiz, Orly Mouallem, Daphna Miron, Nina Gur-Arie, Joseph Klein